North Carolina legislators return to Raleigh in November with a pressing regulatory challenge: deciding how to control the sale of intoxicating hemp products that have flooded the state's market in recent months.
The state's hemp industry has grown rapidly since the 2018 Farm Bill federally legalized hemp, creating a legal gray area for products containing delta-8 THC and other psychoactive cannabinoids derived from hemp. These products, sold in gas stations and smoke shops across North Carolina, occupy a legal limbo that lawmakers say demands immediate attention.
"We are not in any way convinced that we are definitely moving to be a marijuana-legal state," said Clayton Henkel of NC Newsline. "It could happen, but it may not."
The statement reflects the political reality in North Carolina, where medical marijuana bills have stalled despite bipartisan support, while hemp-derived intoxicating products remain widely available without age restrictions or potency limits in many counties.
The Regulatory Gap
North Carolina's situation mirrors challenges facing lawmakers in at least 15 other states where hemp-derived THC products have created an unregulated market. The 2018 Farm Bill legalized hemp containing less than 0.3% delta-9 THC by dry weight, but manufacturers quickly developed methods to produce intoxicating compounds like delta-8, delta-10, and THC-O from legal hemp.
The result has been a de facto legal market for psychoactive products that exists outside the state's controlled substances framework. Law enforcement officials and some health advocates have raised concerns about product safety, youth access, and the lack of testing requirements.
Several North Carolina municipalities have already taken action locally. Charlotte-Mecklenburg banned the sale of intoxicating hemp products earlier this year, and other jurisdictions have implemented age restrictions or licensing requirements. But the patchwork of local regulations has created confusion for retailers and consumers alike.
Political Landscape
The hemp regulation debate comes as North Carolina continues to debate broader marijuana policy. A medical cannabis bill passed the state Senate in 2023 but failed to advance in the House, where Republican leadership has been skeptical of expanding marijuana access.
Some lawmakers see hemp regulation as a separate issue from marijuana legalization, arguing that controlling intoxicating hemp products doesn't require taking a position on cannabis policy. Others view the two issues as interconnected, particularly as federal marijuana rescheduling discussions continue.
The timing of the November session puts added pressure on legislators. The General Assembly typically handles major policy decisions during its long session in the spring and summer, leaving the fall short session for budget adjustments and urgent matters. The hemp issue has been elevated to short session status, indicating leadership views it as requiring immediate action.
What's Next
Legislators have several regulatory options under consideration. These range from outright bans on intoxicating hemp products to creating a licensed and regulated market similar to alcohol. A middle-ground approach could include age restrictions, potency limits, testing requirements, and retail licensing without fully prohibiting the products.
Industry groups representing hemp manufacturers and retailers have lobbied for regulations rather than prohibition, arguing that thousands of jobs and hundreds of small businesses depend on the hemp market. Public health organizations have pushed for stricter controls, particularly regarding youth access and product labeling.
The November session begins on November 18. Any hemp regulations passed would likely take effect in early 2025, giving retailers time to comply with new requirements.
The outcome in North Carolina could influence hemp policy debates in other states grappling with similar regulatory questions as federal guidance remains limited.
This article is based on original reporting by www.marijuanamoment.net.
